We have previously shown that capsaicin-sensitive sensory nerves contribute to the regulation of normal cardiac function and to the development of cardiac adaptation to ischemic stress; however, the underlying molecular mechanisms remain unknown. Therefore, here we assessed cardiac functional alterations and relative gene expression changes by DNA microarray analysis of 6400 genes in rat hearts 7 days after the end of systemic capsaicin treatment protocol leading to selective sensory chemodenervation. Capsaicin pretreatment resulted in a cardiac dysfunction characterized by elevation of left ventricular end-diastolic pressure and led to altered expression of 80 genes of known function or homology to known sequences. Forty-seven genes exhibited significant up-regulation and 33 genes were down-regulated (changes ranged from -3.9 to +4.8-fold). The expression changes of 10 selected genes were verified, and an additional 11 genes were examined by real-time quantitative PCR. This is the first demonstration that gene expression changes in the heart due to capsaicin pretreatment included vanilloid receptor-1 (capsaicin receptor), transient receptor potential protein, GABA receptor rho-3 subunit, 5-hydroxytryptamine 3 receptor B, neurokinin receptor 2, endothelial nitric oxide synthase, matrix metalloproteinase-13, cytochrome P450, farnesyl-transferase, ApoB, and leptin. None of the genes have been previously shown to be involved in the mechanism of the cardiac functional effects of sensory chemodenervation by capsaicin. We conclude that capsaicin-sensitive sensory nerves play a significant role in the regulation of a variety of neuronal and non-neuronal genes in the heart and possibly in other tissues as well. apsaicin is a highly selective sensory neurotoxin that leads to a selective functional blockade and/or ablation of a morphologically well-defined population of primary sensory neurons (1, 2). Hence, capsaicin has become one of the most important probes for investigations of sensory neural pathology and pharmacology (see ref 3-5 for reviews). However, it has been appreciated only in the last decade that the selective action of capsaicin and related compounds on a subset of sensory nerve fibers is mediated at least in part by an agonist activity on a ligand-gated ion channel called capsaicin receptor or the transient receptor potential vanilloid receptor-1 (TRPV1; ref 6). The recognition that the capsaicin receptor also functions as a principal receptor for protons and eicosanoids implies that capsaicin receptor antagonists may be of value in the treatment of inflammatory hyperalgesia and pain (7). However, the discovery of capsaicin receptor-expressing cells in the brain as well as in non-neural tissues places the capsaicin receptor in a much broader perspective than peripheral pain perception and is hoped to identify further, yet unsuspected, indications for vanilloid therapy (8, 9). However, the exact role of capsaicin-sensitive sensory nerves and capsaicin receptor in cellular mechanisms and the mechanisms that regulate capsaicin receptor gene expression under pathological conditions are unknown. A better understanding of these pathways has obvious implications for rational drug development acting on the capsaicin receptor (10). However, the traditional biochemical and pharmacological approaches have been insufficient so far to explore the key cellular events in the heart due to depletion of sensory nerves. Three years ago, Szallasi and Fowler (10) envisioned in their review that the application of gene chip technologies will address the global profile of vanilloid-induced changes in gene expression and their contribution to cellular events. Surprisingly, no attempt has been made so far to explore gene expression changes induced by selective chemodenervation of sensory nerves by systemic capsaicin pretreatment in any tissues.
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In contrast to the adrenergic and cholinergic innervation of the heart, less attention has been paid to the functional significance of the rich sensory innervation of the myocardium and the coronary vascular system. Sensory nerves have a strong influence on cardiac function and adaptive responses due to their nitric oxide (NO) and vasoactive peptide content, such as calcitonin generelated peptide (CGRP) and substance P (3, 5, 11, 12) . The thin sensory nerve endings act as potential sensor machinery for ischemia, since ischemia, hypoxia, lactate, K + , and low pH were shown to stimulate cardiac sensory nerves in association with a release of their transmitters (see refs 3, 13 for reviews). By the use of capsaicin, we and others (14, 15) have previously shown the involvement of cardiac sensory nerves in cardiac adaptation to ischemic stress, i.e., ischemic preconditioning. We have recently shown that capsaicin-sensitive sensory nerves play a role in the regulation of cardiac NO-cGMP system (16) and in the mechanism of doxorubicin-induced heart failure (17) . Therefore, it seems that capsaicin-sensitive cardiac nerves regulate a series of complex cellular events contributing to physiological and pathological myocardial function.
In the hope of identifying new cellular pathways regulated by capsaicin-sensitive cardiac sensory nerves, here we have used cDNA microarrays of 6400 genes to monitor gene expression pattern of the heart associated with chemodenervation of sensory nerves by systemic capsaicin pretreatment. Cardiac functional parameters were also analyzed, and gene expression changes obtained by microarray assay were verified by RT-PCR in the case of selected genes with high biological significance. 
MATERIALS AND METHODS
The investigation conforms to the Guide for the Care and Use of Laboratory Animals published by the U.S. National Institutes of Health (NIH publication No. 85-23, revised 1996) and was approved by local ethics committees.
Selective sensory denervation by capsaicin and its verification
Male Wistar rats (300-350 g), housed in a room maintained at 12 h light-dark cycles and a constant temperature of 22 ± 2°C, were treated with capsaicin subcutaneously in the sequence of 10, 30, and 50 mg/kg single daily doses for 3 days for selective chemodenervation of capsaicinsensitive sensory nerves as described previously (14, 16) . Capsaicin (1% w/v, Fluka, Buchs, Switzerland) was dissolved in physiological saline containing 6% v/v ethanol and 8% v/v Tween 80. Animals treated with equivalent amounts of the solvent served as controls. All injections of capsaicin and its solvent were given under general anesthesia using diethyl-ether. Seven days after the last injection when depletion of peptide-containing myocardial sensory nerves is already complete (14, 16) , hearts from capsaicin-and solvent-treated animals were isolated and perfused for measurement of cardiac function and biochemical parameters. Similar to our previous studies (14, 16) , systemic capsaicin treatment in the present series of experiments resulted in an elimination of CGRP immunoreactivity from the heart tissue as assessed by immunohistochemistry (see below) and a lack of CGRP release from the heart as assessed by radioimmunoassay as described previously (14, 16, 17 ; n=3 in each group, data not shown).
Perfusion protocol and measurements of cardiac function in isolated rat hearts
Animals were anesthetized with diethylether and given 500 U/kg heparin. Hearts from normal and capsaicin-treated rats (n=8 in each groups) were then isolated and perfused in Langendorff mode with an oxygenated, normothermic Krebs-Henseleit buffer for 5 min. Subsequently, the perfusion was switched to a working mode (18, 19) to measure cardiac mechanical functional and hemodynamic parameters including heart rate, coronary flow, aortic flow, left ventricular developed pressure and its first derivatives (+dP/dt max , -dP/dt max ), and left ventricular enddiastolic pressure as described previously (20) . Lactate dehydrogenase release was measured from coronary effluent collected for 5 min at the beginning of the perfusion (18) . At the end of the perfusion protocols, hearts from both groups were frozen and powdered with a pestle and mortar in liquid nitrogen for RNA preparation.
RNA preparation
Total RNA was purified from each group (25-25 mg tissue from each heart) with RNeasy fibrous tissue mini kit from Qiagen according to the manufacturer's instructions as described previously (21) . The quantities and qualities of RNA from each sample were assessed by gel electrophoresis as well as spectrophotometry (NanoDrop spectrophotometer, NanoDrop). Two RNA pools were prepared from each group (n=4, randomly selected from each group) and used in replica experiments. Total RNA was used for microarray analysis as well as for reverse transcription quantitative PCR.
Microarrays and probes
Six thousand four hundred rat gene-specific, amino-modified oligonucleotides were purchased (Sigma-Operon) and were resuspended in 50% dimethyl-sulfoxide/water at a final concentration of 300 fmol/μl. Oligonucleotides were arrayed from 384-well plates onto PXM oligonucleotide slides (Full Moon Biosystems, Sunnyvale, CA) by using a MicroGrid Total Array System (BioRobotics, Cambridge, UK) spotter with 16 pins in a 4 × 4 format. DNA elements were deposited in duplicate in distinct area of the array. The diameter of each spot was ~200 μm. After being printed, slides were incubated in a humid chamber for 14 h at 42°C. Before hybridization, the slides were processed as described previously (22, 23) .
For probe preparation, 2 μg of total RNA were reverse transcribed using poly-dT and random primed Genisphere Expression Array 900MPX Detection System (Genisphrere, Hatfield, PA) in 20 μl total volume using 20 U RNAsin (Fermentas, Vilnius, Lithuania), 1× first strand buffer, and 200 U of RNase H(−) point mutant M-MLV reverse transcriptase (Fermentas). All the other probe preparation steps were done according the manufacturer's instructions (Genisphere). Both the first step cDNA hybridization and the second step capture reagent hybridization were carried out in a Ventana hybridization station (Ventana Discovery, Tucson, AZ) by using the "antibody" protocol. First hybridization was performed at 40°C for 6 h in "FGL2" hybridization buffer (10× Denhardt's solution, 0.25 M sodium phosphate buffer pH 7.0, 1 mM EDTA, 1× SSC, 0.5% SDS), and then 2.5 μl of each Cy5 and Cy3 capture reagents were added to the slides in 200 μl "Chiphyb" hybridization buffer (Ventana) and incubated at 42°C for 2 h. After hybridization, the slides were washed in 0.2× SSC twice at RT for 10 min and then dried and scanned.
Scanning and data analysis
Each array was scanned under a green laser (543 nm for Cy3 labeling) or a red laser (633 nm for Cy5 labeling) using a ScanArray Lite (GSI Lumonics, Billerica, MA) scanning confocal fluorescent scanner with 10 μm resolution (laser power: 85% for Cy5 and 90% for Cy3, Gain: 80% for Cy5 and 75% for Cy3) (21) . Scanned output files were analyzed using the GenePix Pro5.0 software (Axon Instruments Inc., Foster City, CA). Each spot was defined by automatic positioning of a grid of circles over the image. For each channel, the median values of feature and local background pixel intensities were determined (21, 24) . The background corrected expression data were filtered for flagged spots and weak signal. Technical replicates on the same array were averaged. Data were excluded in cases where technical replicates were significantly different. Normalization was performed using the print-tip LOWESS method (25) . Next, we used the one-sample t test to determine the genes to be regarded as regulated in response to treatment. Logarithm was taken from each expression ratio to fulfill the requirement of the t test for a normal distribution. Genes for which the mean of log ratios across the biological replicates were equal to zero at a significance level α = 0.05 are considered to have an unchanged expression. On the other hand, genes having a P value smaller than α and the average fold change (increase or decrease) of the four data points were at least 1.9 times were considered as regulated genes.
Real-time quantitative reverse transcription-PCR
Real-time quantitative reverse transcription-PCR (QRT-PCR) was performed on a RotorGene 2000 instrument (Corbett Research, Sydney, Australia) with gene-specific primers and SybrGreen protocol to confirm expression changes of 10 selected genes observed by microarrays (Table 1 ). An additional 11 genes strongly related to sensory neural signaling but not available on the DNA-chip were also investigated by QRT-PCR (Table 1) . Two micrograms of total RNA from each sample were reverse transcribed in the presence of random primers in a total volume of 20 μl. After dilution with 20 μl of water, 1 μl of the diluted reaction mix was used as template in QRT-PCR. The 20 μl reaction volume contained 0.2 mM of dNTP, 1× PCR reaction buffer (ABGene, Epsom, UK), 6 mM of each primer, 4 mM of MgCl 2 , 1× SYBR Green I (Molecular Probes, Eugene, OR) at final concentration, and 0.5 U of thermostart Taq DNA polymerase (ABGene). The amplification was carried out with the following cycling parameters: 600 s heat start at 95°C, 45 cycles of denaturation at 95°C for 25 s, annealing at 60°C for 25 s, and fluorescence detection at 72°C for 15 s. Relative expression ratios were normalized to β-actin. Nontemplate control sample was used for each PCR run to check the genomic DNA contaminations of cDNA template. Analysis of results was done using Pfaffl method (26) . With the use of this calculation method, differences between the amplification efficiencies of reactions could be corrected.
CGRP and TRPV1 immunohistochemistry
For immunohistochemical studies, additional groups of rats treated with capsaicin (n=3) or its solvent (n=3) were perfused via the left heart ventricle with 4% formaldehyde in phosphate buffer (0.1 M, pH 7.4) 1 wk after the completion of the treatment. The hearts and the 8th cervical and 1-3rd thoracic dorsal root ganglia innervating the heart (27) were removed, and after a postfixation period of 3 h, they were placed in a buffer solution and stored at 4°C until sectioning. Transverse sections through the ventricles and sections from the dorsal root ganglia were cut at a thickness of 20 μm and were processed for immunohistochemical staining with the indirect immunofluorescence technique by using a rabbit and guinea pig polyclonal antisera raised against CGRP (Sigma Chemicals, St. Louis, MO, 1:500) and TRPV1 (Neuromics Antibodies, Bloomington, MN, 1:1000). Goat anti-rabbit and donkey anti-guinea pig IgGs labeled with Cy3 (carboxymethylindocyanin, Jackson ImmunoResearch Laboratories Inc., West Grove, PA, 1:500) were used as secondary antibodies. The specimens were viewed under a Leitz DMLB fluorescence microscope equipped with an appropriate filter combination and photographed with a digital camera.
RESULTS

Cardiac function
Sensory chemodenervation by systemic capsaicin pretreatment resulted in a significant increase in left ventricular end-diastolic pressure; however, other hemodynamic parameters such as heart rate, coronary flow, aortic flow, and left ventricular developed pressure and its first derivatives (+dP/dt max, -dP/dt max ) were not changed (Table 2) , and no lactate dehydrogenase release was detected (data not shown) as assessed in "working" hearts isolated from rats 7 days after the capsaicin pretreatment protocol.
Page 5 of 22 (page number not for citation purposes)
Gene expression
Among the 6400 rat genes examined by DNA microarray in the present study an average of 3324 showed significant intensity (see Materials and Methods for statistical calculations) and 2.6% (86 genes) showed significantly altered expression: 47 genes exhibited significant up-regulation (Table 3 ) and 33 were down-regulated (Table 4) 7 days after the end of the systemic capsaicintreatment protocol. Out of the 86 genes, 80 genes of known function or homology to known sequences and 6 expressed sequence tags (ESTs, not presented in the tables) with unknown function or homology were detected. Genes with altered expression were from various functional clusters, such as neural function, signal transduction, protein processing, cell adhesion, gene regulation, defense response, metabolism including lipid metabolism, and transport processes (Tables 3 and 4 ). The gene expression changes ranged from -3.9-to +4.8-fold (Tables 3 and 4 ).
To confirm the differential expression of genes revealed by microarray analysis of rat hearts after capsaicin treatment, we have selected 10 genes differentially expressed in hearts due to capsaicin pretreatment for real-time QRT-PCR analysis ( Table 5 ). The differential expression of all the 10 selected genes was confirmed by the QRT-PCR data. In the case of vanilloid receptor subtype-1, apolipoprotein B, voltage-dependent calcium channel gamma-3 subunit, farnesyl transferase, farnesyl diphosphate synthase, and matrix metalloproteinase-13, the QRT-PCR showed very similar values to microarray data. However, a higher degree of change was observed in the repression of leukotriene B4 receptor 2 and cytochrome P450 subfamily 2A polypeptide 1 genes, and a lower degree of change was observed in the up-regulation of GABA receptor rho-3 subunit and kinesin-related protein 6 genes by QRT-PCR when compared with DNA microarray data.
The effect of sensory chemodenervation by capsaicin on expression of an additional 11 genes strongly related to sensory neural signaling but that were not available on the DNA-chip was also investigated by QRT-PCR (Table 1 ). The expression of neurokinin B was significantly downregulated by capsaicin pretreatment (Table 6) ; however, mRNAs of α calcitonin gene-related peptide, β calcitonin gene-related peptide, and substance P were not found in control or capsaicin-pretreated groups (data not shown). Neurokinin receptor 2 mRNA was down-regulated due to capsaicin pretreatment (Table 6 ), but the expression of neurokinin receptor 1 was not changed significantly (data not shown). No mRNA for neurokinin receptor 3 was found in the control or capsaicin-treated groups (data not shown). Whereas endothelial nitric oxide synthase (NOS-3) was significantly down-regulated by capsaicin-treatment (Table 6 ), the expression of neuronal nitric oxide synthase (NOS-1), inducible nitric oxide synthase (NOS-2), and soluble guanylate cyclase was not affected (data not shown).
CGRP and TRPV1 immunohistochemistry
As it is shown in Fig. 1A , TRPV1 immunohistochemistry revealed many small to medium-sized and few small neurons showing moderate and very intense staining, respectively, in the C8-Th3 dorsal root ganglia, which provide the sensory innervation of the heart (27) . TRPV1-immunoreactive neurons could not be demonstrated after capsaicin treatment (Fig. 1B) . However, in agreement with previous findings (28, 29), we could not detect TRPV1-immunoreactive nerves in the heart in control or capsaicin-treated groups using conventional immunohistochemical techniques. CGRP is the major sensory neuropeptide localized in afferent nerves; therefore, CGRP immunohistochemistry is a reliable tool for the demonstration of the peptidergic sensory innervation of most somatic and visceral organs, including the heart (30, 31) . Accordingly, CGRP immunohistochemistry demonstrated many immunoreactive axons in the heart ventricles of control rats (Fig. 1C ). In agreement with previous studies, capsaicin treatment resulted in a practically complete depletion of CGRP-containing nerves from the ventricular myocardium, indicating a substantial sensory denervation of the heart ( Fig. 1D; refs 14, 17, 30, 32) .
DISCUSSION
This is the first demonstration that selective sensory chemodenervation induced by systemic capsaicin treatment results in a cardiac dysfunction characterized by an increase in left ventricular end-diastolic pressure and leads to extensive changes in cardiac expression of genes from various functional clusters.
Cardiac function
Similar to our previous results (14, 16) , left ventricular end-diastolic pressure was significantly increased in the capsaicin-pretreated group; however, other hemodynamic parameters including coronary flow were not changed ( Table 2 ) and no LDH release was detected (data not shown) in the present study, which shows that capsaicin pretreatment did not result in restriction of coronary circulation and development of myocardial ischemia. In the light of previous studies showing that systemic capsaicin treatment results in a loss of primary sensory neurons (4, 33), depletion of cardiac sensory neuropeptides and nitric oxide, (14, 17) and a reduction of vanilloid receptor binding of primary afferents (34) , our present findings show that capsaicin-induced changes in cardiac function and gene expression pattern of the rat heart can be attributed to the well-established selective sensory chemodenervation of the heart and other organs but not to development of myocardial ischemia caused by capsaicin. It should be noted that the deleterious consequences of impaired sensory nerve function are even more clearly manifested under pathological conditions such as ischemic preconditioning (14) , myocardial infarction (35) , and adriamycin-induced cardiomyopathy (17) , where several cardiac functional parameters in addition to left ventricular end-diastolic pressure deteriorates.
Expression changes of genes with known neural function
We have found here that capsaicin pretreatment resulted in an up-regulation of several genes with known function in the nervous tissue. This is the first demonstration that capsaicin pretreatment, interestingly, resulted in a significant up-regulation of its receptor, TRPV1 and some other related genes such as the transient receptor potential (TRP) protein 5 and the vanilloid receptor-related osmotically active channel. Up-regulation of TRPV1 gene has been also confirmed by QRT-PCR in our present study. The TRP proteins are six transmembranecontaining subunits that combine to form cation-selective ion channels. TRPs are widely distributed and sense local changes in stimuli ranging from light to temperature and osmolarity. Mammals contain at least 22 distinct genes encoding these ion channels (36) . TRPs are expressed in endothelial cells as well and their function includes regulation of intracellular calcium signaling (37) . The vanilloid receptor-related osmotically activated channel is a novel cation-selective channel gated by exposure to hypotonicity within the physiological range; therefore, it is considered as an osmoreceptor. In the nervous system, the channel is expressed in neurons of the circumventricular organs and other neurosensory cells, including inner-ear hair cells, sensory neurons, and Merkel cells responsive to systemic osmotic pressure. It seems that in the heart, capsaicin-sensitive neurons may regulate the expression of osmoreceptors (38) . Further biochemical and pharmacological studies are necessary to elucidate the role of sensory nerves in the regulation of TRPs including TRPV1 in the different cell types of the heart tissue. Another gene up-regulated significantly by capsaicin is synaptotagmin VII in our present study. Synaptogamins have been the candidates for the Ca 2+ sensor that couples local rise in Ca 2+ to neurotransmitter release (39) . Synaptotagmin IX has been previously shown to interact strongly with the TRPV1 N-terminal domain and plays a role in the exocytosis of TRPV1 to the cell surface (40) .
Capsaicin pretreatment resulted in a significant up-regulation of GABA receptor rho-3 subunit in the heart in our present study as assessed by DNA microarray and also confirmed by QRT-PCR. The expression of GABA-A receptor on capsaicin-sensitive fiber axons has been previously shown (41) , and GABA-A-mediated positive inotropism in guinea-pig isolated left atria has been proven to be dependent on cardiac capsaicin-sensitive nerves (42) . The mechanism by which chemodenervation by capsaicin regulates GABA receptors needs to be elucidated.
Capsaicin pretreatment led to an up-regulation of a putative ion channel protein gene, phosphohippolin. Phosphohippolin may play a role in the excitability of neurons in the central nervous system (43, 44) , but its function in the heart is not known. Neural visinin-like calcium binding protein 3, another gene up-regulated by capsaicin pretreatment in our present study, has been suspected to be involved in dendritic arborization and postsynaptic function in cerebellar Purkinje cells (45) ; however, its function in the heart is not known. Capsaicin pretreatment upregulated potassium channel Q4 in the heart. Potassium channel Q (KCNQ) genes encode a growing family of six transmembrane domains, single pore-loop, K + channels that have a wide range of physiological correlates (46), e.g., mutations in KCNQ4 cause hereditary deafness (47). The role of KCNQ4 in cardiac physiology is not known.
Our present finding that selective chemodenervation by systemic capsaicin pretreatment resulted in an up-regulation of several genes with neural function, including its own receptor TRPV1 and other TRP-related genes, is somewhat unexpected. Previous studies have shown that systemic capsaicin treatment induced degeneration of dorsal root ganglion cells (48, 49) and depletion of sensory neuropeptides, including CGRP, from cardiac nerves due to degeneration of sensory nerves (32, 50) . In the present study, we have shown that capsaicin treatment resulted in a depletion of CGRP-containing afferent nerves and TRPV1-immunoreactive neurons from the heart and spinal ganglia, respectively. Collectively, these findings indicate that capsaicin treatment resulted in a profound sensory denervation of the heart. Therefore, the present finding that shows an increase in cardiac TRPV1 gene expression in the heart in response to capsaicin treatment is rather unexpected. The possibility that this may result from an increased expression of TRPV1 in sensory nerves presumably spared by the capsaicin treatment cannot be excluded but seems unlikely in the light of previous findings detailed above. These findings may suggest that the increased expression of TRPV1 and related genes after systemic capsaicin treatment may be attributed to up-regulation of these cardiac genes of non-neural origin. Indeed, recent studies revealed a marked but transient expression of TRPV1 immunoreactivity in cardiomyocytes of the embryonic and early postnatal heart of the rat (29) . Hence, a re-expression of TRPV1 in cardiac muscle in response to sensory denervation may explain the increase in TRPV1 mRNA after
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capsaicin treatment. This assumption is supported by the findings that suggest parallel but inverse developmental changes in TRPV1 expression of cardiomyocytes and cardiac innervation. Indeed, the increase in the density of cardiac peptidergic sensory nerves (51) parallels the decrease in TRPV1 expression of the cardiac muscle (29) . Since TRPV1 has also been detected in endothelial cells (52), this may represent another possible source of cardiac TRPV1 and other genes of neural function. Although we attempted to reveal the localization of TRPV1 receptors in the heart using immunohistochemistry, we were not able to demonstrate TRPV1 immunoreactivity in the hearts of control or capsaicin-treated animals, which is in agreement with previous findings (28, 29) . Since we have shown in this study using both DNA-microarray and RT-PCR that TRPV1 mRNA was up-regulated in the heart of capsaicin treated animals, it seems, therefore, that up-regulation of TRPV1 mRNA does not lead to TRPV1 protein synthesis in the heart, or the available TRPV1 antibody, in contrast to findings in the dorsal-root ganglia, does not recognize TRPV1 protein in the heart possibly due to significant mRNA processing and/or post-translational modification.
We have found here that capsaicin pretreatment resulted in a down-regulation of some genes with known neural function as assessed by DNA-microarray, such as 5-hydroxy-tryptamin-3 receptor B. It has been previously shown that the activation of 5-hydroxy-triptamin-3 receptors on the sensory nerve terminals brought about ruthenium red-sensitive Ca 2+ influx and release of CGRP from capsaicin-sensitive stores in guinea pig atrium (53). The expression of neurokinin B was significantly down-regulated by capsaicin pretreatment; however, mRNAs of other sensory neuropeptides, such as α calcitonin gene-related peptide, β calcitonin gene-related peptide, and substance P, were below the detection limit in both control and capsaicin-pretreated groups as measured by RT-PCR. As the location of neuropeptide synthesis is known to be the ganglion cells, the presence of neurokinin B mRNA in control hearts in the present study may raise the possibility of a non-neural origin of neurokinin B synthesis in the heart as also observed by others in the ovary (54). Neurokinin receptor 2 mRNA was down-regulated due to capsaicin pretreatment, the expression of tachykinin 1 receptor was not changed significantly, and no mRNA for neurokinin receptor 3 was found in the control or capsaicin-treated groups by RT-PCR. Since very little is known about the role of tachykinins and their receptors in the regulation of cardiac function, the present findings may be of great interest for further investigations and development of neurokinin receptor modulators (see for review ref 55).
Expression changes of genes with known non-neural function
Selective sensory chemodenervation by systemic capsaicin pretreatment resulted in significant changes in transcription of several genes with a variety of known physiological function not specific for nervous tissue, such as gene regulation, signal transduction, protein processing, and metabolism. Capsaicin pretreatment resulted in an up-regulation of some genes involved in cellular defense response and lipid metabolism; however, it led to a down-regulation of some genes involved in cellular transport processes (see Tables 3 and 4) . The mechanisms by which sensory chemodeneravtion with capsaicin lead to altered regulation of a series of genes with a variety of cellular function would be interesting to reveal, as still little is known about the function of most of these genes in the heart. It is of great interest that capsaicin-sensitive nerves may regulate cardiac expression of, e.g., apolipoprotein B, voltage sensitive calcium channels, the obesity-related leptin gene, the mevalonate pathway-related genes farnesyl transferase, and farnesyl diphosphate synthase, as well as matrix metalloproteinase-13. Whereas endothelial nitric oxide synthase (NOS-3) was significantly down-regulated by capsaicin-treatment, the expression of neuronal nitric oxide synthase (NOS-1), inducible nitric oxide synthase (NOS-2), and soluble guanylate cyclase was not affected. This is in agreement with our previous findings showing a reduced NO content of the myocardium due to capsaicin pretreatment (14) and further suggests that this might be due to a down-regulation of endothelial NOS. Altered expression of metabolic genes and voltage-dependent Ca 2+ channel genes may explain the deterioration of cardiac function in response to sensory chemodenervation by capsaicin; however, the contribution of other genes to the regulation of cardiac function in health and disease is not known and requires further in-depth studies.
Limitations of the present study
In the case of some genes, we have found here some discrepancies in the extent of their expression changes when assessed by microarray or by QRT-PCR. Some discrepancies in some cases between DNA microarray and QRT-PCR studies have also been reported previously (56, 57) and could be explained by cross-hybridization of homologous sequences or by other experimental variables introduced by hybridization, labeling, data processing, and normalization variations during microarray analysis. As the direction and the statistical significance of changes in all the selected genes were verified by QRT-PCR data, we may conclude that the data presented by our microarray analysis are highly reproducible.
As RNA was prepared from the ventricles of blood-free hearts, in addition to myocardial cells, smooth muscle cells, endothelial cells, and other cell types found in the ventricular tissue might have contributed to changes in gene expression. However, myocardial cells predominate in ventricular tissue; therefore, the major contribution to the gene expression changes observed in this study can be attributed to this cell type.
As systemic capsaicin treatment has been applied for sensory chemodenervation of the heart in the present study, capsaicin-induced changes in cardiac function and gene expression can be attributed not only to sensory chemodenervation of the heart but also to systemic chemodenervation, which may cause neurohumoral, behavioral, and other extracardiac biochemical and physiological changes that could influence cardiac function and gene expression.
How changes in cardiac gene expression with known neural and non-neural functions are manifested in deterioration of cardiac function in normal or diseased heart is not answered by this study. This is the first gene-discovery study on the effect of sensory nerves on the heart, which revealed several unexpected changes in gene expression in response to systemic sensory chemodenervation. Further in-depth studies investigating each of the altered genes and their protein products will reveal their exact role in the regulation of biochemical pathways affecting cardiac function.
CONCLUSIONS
We conclude that selective sensory chemodenervation by systemic capsaicin pretreatment leads to a moderate cardiac mechanical dysfunction and significant changes in expression of a variety of genes of both neural and non-neural functions in the heart tissue. This indicates that capsaicin-sensitive sensory nerves may play a significant role in the regulation of the expression of a variety of neuronal and non-neuronal genes in the heart and possibly in other tissues as well. The function of these genes in the heart in relation with capsaicin sensitive nerves is not known; therefore, our present findings may open new directions in the research of the effects of capsaicin and other synthetic agonists and antagonists on vanilloid receptors. thoracic dorsal root ganglion of a control rat (A). TRPV1-immunoreactive spinal ganglion cells cannot be detected in the capsaicin-pretreated rat (B). CGRP-immunoreactive nerve fibers in the left ventricle of the heart of a control rat (C). Capsaicin treatment resulted in a complete depletion of CGRP-immunoreactive nerves from the heart (D). Scale bar in D indicates 50 µm and applies for all microphotographs.
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